Suppr超能文献

儿科烧伤三级护理机构的阿片类药物处方实践:是否是时候改变了?

Opioid prescribing practices in a pediatric burn tertiary care facility: Is it time to change?

机构信息

University of Texas Southwestern Medical Center, Department of Anesthesiology and Pain Management, United States.

University of Texas Southwestern Medical Center, Department of Clinical Sciences, United States.

出版信息

Burns. 2020 Feb;46(1):219-224. doi: 10.1016/j.burns.2019.07.016. Epub 2019 Dec 18.

Abstract

Opioids are the mainstay therapy in burned adults. Little data in the pediatric burn population exists that elucidates opioid prescribing practices. The primary purpose of this report is to quantify opioid and non-opioid analgesic use in pediatric burn patients admitted to a tertiary referral burn center. A retrospective audit of hospital charts and discharge records for patients <18 years old from March 2016 to March 2017 was performed. Opioid amounts were converted to either oral morphine miligram equivalents (MME) or oral MME per day and subsequently adjusted for age in kilograms (kg). Of the 226 patients, 223 (98.7%) were administered an opioid during admission. The median total opioid amount administered during admission was 0.4 (IQR: 0.3-0.6) mg oral MME per kilogram per day. Anecdotally, doses above 1 mg/kg/day are considered high risk for opioid tolerance. The median total opioid amount prescribed upon discharge was high at 3.9 (IQR: 2.3, 5.6) mg of oral MME per kilogram. Hydrocodone (96.0%) was the most common opioid administered, followed by morphine (88.1%). The most commonly prescribed discharge opioid was hydrocodone (95.4%). Non-opoioid analgesia during admission was used in 112 patients (49.6%). This study provides novel insight into the opioid practices at a tertiary burn center for pediatric patients, with our analysis showcasing high usage of opioids during admission and discharge for burn analgesia. It emphasizes the need to expand beyond opioids for burn analgesia and the importance of promoting non-opioid, multimodal analgesia in the pediatric burn population.

摘要

阿片类药物是成人烧伤患者的主要治疗方法。在儿科烧伤人群中,很少有数据可以阐明阿片类药物的处方实践。本报告的主要目的是量化在三级转诊烧伤中心接受治疗的儿科烧伤患者的阿片类药物和非阿片类镇痛药的使用情况。对 2016 年 3 月至 2017 年 3 月期间年龄小于 18 岁的住院患者的病历和出院记录进行了回顾性审核。将阿片类药物的用量转换为口服吗啡毫克当量(MME)或口服 MME 每天,并按年龄(kg)进行调整。在 226 名患者中,223 名(98.7%)在住院期间接受了阿片类药物治疗。住院期间给予的阿片类药物总量中位数为 0.4(IQR:0.3-0.6)mg/kg/天。据推测,每天 1mg/kg 以上的剂量被认为有阿片类药物耐受的风险。出院时开具的阿片类药物总量中位数较高,为 3.9(IQR:2.3,5.6)mg/kg。氢可酮(96.0%)是最常用的阿片类药物,其次是吗啡(88.1%)。最常开的出院阿片类药物是氢可酮(95.4%)。112 名患者(49.6%)在住院期间使用了非阿片类镇痛药。本研究为三级烧伤中心儿科患者的阿片类药物实践提供了新的见解,我们的分析表明,在烧伤镇痛方面,住院和出院期间阿片类药物的使用量都很高。这强调了需要扩大烧伤镇痛的范围,超越阿片类药物,并重视在儿科烧伤人群中推广非阿片类、多模式镇痛。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验